Sands Capital Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Sands Capital Management, LLC
- $31.4 Billion
- Q3 2024
A detailed history of Sands Capital Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Sands Capital Management, LLC holds 5,118,255 shares of RARE stock, worth $230 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
5,118,255
Previous 5,354,750
4.42%
Holding current value
$230 Million
Previous $220 Million
29.19%
% of portfolio
0.91%
Previous 0.68%
Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
326Shares Held
85.7MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$447 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$252 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$187 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$138 Million0.02% of portfolio
-
Alkeon Capital Management LLC New York, NY3.01MShares$135 Million0.29% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.15B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...